European journal of gastroenterology & hepatology, 34(10), 983-992. Lippincott Williams and Wilkins European Journal of Gastroenterology & Hepatology, 34, 983-992 European journal of gastroenterology & hepatology, 34(10), 983-992. Lippincott Williams & Wilkins European Journal of Gastroenterology & Hepatology, 34, 10, pp. 983-992 European Journal of Gastroenterology & Hepatology, 34(10), 983-992. LIPPINCOTT WILLIAMS & WILKINS ten Bokkel Huinink, S, de Jong, D C, Nieboer, D, Thomassen, D, Steyerberg, E W, Dijkgraaf, M G W, Bodelier, A G L, West, R L, Römkens, T E H, Hoentjen, F, Mallant, R C, van Tuyl, B A C, Mares, W G N, Wolfhagen, F H J, Dijkstra, G, Reijnders, J G P, de Boer, N K, Tan, A C I T L, van Boeckel, P G A, Tack, G J, van Asseldonk, D P, D'Haens, G R A M, van der Woude, C J, Duijvestein, M & de Vries, A C 2022, ' Validation and update of a prediction model for risk of relapse after cessation of anti-TNF treatment in Crohn's disease ', European journal of gastroenterology & hepatology, vol. 34, no. 10, pp. 983-992 . https://doi.org/10.1097/MEG.0000000000002403
Alimentary Pharmacology & Therapeutics, 52(1), 123-134. Wiley Biemans, V B C, van der Woude, C J, Dijkstra, G, van der Meulen-de Jong, A E, Löwenberg, M, de Boer, N K, Oldenburg, B, Srivastava, N, Jansen, J M, Bodelier, A G L, West, R L, de Vries, A C, Haans, J J L, de Jong, D, Hoentjen, F & Pierik, M J 2020, ' Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn’s disease patients with prior failure to anti-TNF treatment ', Alimentary Pharmacology and Therapeutics, vol. 52, no. 1, pp. 123-134 . https://doi.org/10.1111/apt.15745 Alimentary Pharmacology & Therapeutics, 52, 1, pp. 123-134 Alimentary pharmacology & therapeutics, 52(1), 123-134. Wiley-Blackwell Alimentary Pharmacology & Therapeutics Alimentary Pharmacology & Therapeutics, 52(1), 123-134. Wiley-Blackwell Publishing Ltd Alimentary Pharmacology & Therapeutics, 52, 123-134 Alimentary Pharmacology and Therapeutics, 52(1), 123-134. WILEY Alimentary Pharmacology and Therapeutics, 52(1), 123-134
Jama : Journal of the American Medical Association, 323, 3, pp. 237-247 Jama : Journal of the American Medical Association, 323, 237-247 Journal of the American Medical Association, 323(3), 237-247. AMER MEDICAL ASSOC JAMA-Journal of the American Medical Association, 323(3), 237-247. American Medical Association